Download presentation
Presentation is loading. Please wait.
Published byHoward Dennis Modified over 5 years ago
1
Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization Peter A. Soden, MD, Sara L. Zettervall, MD, MPH, Klaas H.J. Ultee, BSc, Bruce E. Landon, MD, MBA, A. James O'Malley, PhD, Philip P. Goodney, MD, MS, Randall R. DeMartino, MD, MS, Shipra Arya, MD, Marc L. Schermerhorn, MD Journal of Vascular Surgery Volume 64, Issue 6, Pages e1 (December 2016) DOI: /j.jvs Copyright © 2016 Society for Vascular Surgery Terms and Conditions
2
Fig Cumulative adjusted survival for patients with critical limb ischemia (CLI) undergoing (A) bypass and (B) endovascular intervention. ASA, Aspirin; CI, confidence interval; DAPT, dual antiplatelet therapy; HR, hazard ratio. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
3
Supplementary Fig (online only)
Cumulative adjusted survival for patients undergoing (A) bypass and (B) endovascular intervention. ASA, Aspirin; CI, confidence interval; DAPT, dual antiplatelet therapy; HR, hazard ratio. Journal of Vascular Surgery , e1DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.